FDA approves amivantamab for head and neck cancer

• by Mouj Hijazi

• November 6, 2026

AI may cut breast biopsy review time by 44%

A paired-reader study found that pathologists maintained high diagnostic agreement while reviewing breast biopsy slides faster with AI assistance.

• by Andrea Surnit

• November 3, 2026

• 3 min

FDA expands talazoparib use in prostate cancer

The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .

• by Mouj Hijazi

• October 27, 2026

• 3 min

Photodynamic therapy gains FDA approval for superficial BCC

Phase 3 trial data showed greater clinical and histological clearance than with placebo photodynamic therapy.

• by Kathryn Wighton

• September 15, 2026

• 2 min